September 2019 tender notification

Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes

Please note that for any changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H), suppliers are required to notify any changes to PHARMAC and the Pharmacy Guild of New Zealand by:

• For new listings, by 4pm on the 14 October 2019 or the 5^th of the month prior to listing, whichever is earlier
• For price changes, by 4pm on the 12^th of the month prior to the date of subsidy change

PHARMAC cannot list a product (and pharmacies cannot claim) without this information. 

More information about this process and NOPC forms can be found on our website.

Suppliers are required to ensure that a Pharmacode has been obtained from the Pharmacy Guild of New Zealand(external link)  and that a CTPP code has been obtained from the New Zealand Universal List of Medicines(external link). Pharmacodes and CTPP codes must be provided to PHARMAC by the 5th of the month prior to the date of listing, or 10 business days following the market notification date (whichever is earliest). PHARMAC cannot list a product (and pharmacies cannot claim) without the correct Pharmacode.

2018/19 Tender – Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2022

Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule

1. Tenders awarded to pharmaceuticals where at least one other brand is listed.

The decisions were as follows:

Chemical name	Presentation; Pack size and type	Current pack price	New pack price	Sole supply brand (Supplier)	Date of listing	Sole Subsidised Supply date	Brand (Supplier) affected by delisting
Capecitabine	Tab 150 mg; 60 tab, blister pack	$11.15	$10.00	Capercit (Dr Reddy’s)	1 February 2020	1 July 2020	Brinov (REX)
Capecitabine	Tab 500 mg;120 tab, blister pack	$62.28	$49.00	Capercit (Dr Reddy’s)	1 February 2020	1 July 2020	Brinov (REX)

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule

2. Tenders awarded to pharmaceuticals where at least one other brand is listed.

The decisions were as follows:

Chemical name	Presentation; Pack size and type	Current pack price	New pack price	Hospital supply brand (Supplier)	DV Limit	Listing date	Hospital Supply Status date	Brand (Supplier) affected by delisting
Capecitabine	Tab 150 mg; 60 tab, blister pack	$11.15	$10.00	Capercit (Dr Reddy’s)	1%	1 February 2020	1 July 2020	Brinov (REX)
Capecitabine	Tab 500 mg; 120 tab, blister pack	$62.28	$49.00	Capercit (Dr Reddy’s)	1%	1 February 2020	1 July 2020	Brinov (REX)
Moxifloxacin	Inj 1.6 mg per ml, 250 ml bottle; 1 bottle	$70.00	$39.00	Moxifloxacin Kabi (Fresenius Kabi)	1%	1 November 2019	1 April 2020	Avelox IV 400 (Bayer)
Rocuronium bromide	Inj 10 mg per ml, 5 ml ampoule; 10 ampoule pack	$25.95 vial	$31.14 ampoule	Hameln (Max Health)	1%	1 March 2020	1 August 2020	DBL Rocuronium Bromide (Pfizer)

3. Tenders awarded to pharmaceuticals where no brand is listed.

The decisions were as follows:

Chemical name	Presentation; Pack size and type	New pack price	Hospital supply brand (Supplier)	DV Limit	Listing date	Hospital Supply Status date
Bupivacaine hydrochloride with fentanyl	Inj 0.625 mg with fentanyl 2 mcg per ml, 200 ml bag; 10 bag pack	$305.00	Biomed (Biomed)	1%	1 November 2019	1 April 2020

Tender declines - Products where no tender is to be awarded for Sole Subsidised Supply Status or Hospital Supply Status